Clinical Trial Update: Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction? [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating epinephrine-coated syringes for subcutaneous immunotherapy to reduce local and systemic injection reactions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Reactions to Injections
• Subcutaneous Immunotherapy-related Reactions

Drugs mentioned

• epinephrine-coated syringe (epinephrine-coated syringe)

Snippet

Sponsor: Mahidol University | Conditions: Injection Reactions Site, Systemic Reactions | Phase 1, Phase 2 | Status: COMPLETED